close
Advertisement
Can't connect right now! retry

add The News to homescreen

tap to bring up your browser menu and select 'Add to homescreen' to pin the The News web app

Got it!

add The News to homescreen

tap to bring up your browser menu and select 'Add to homescreen' to pin the The News web app

Got it!
AFP
July 1, 2020

Virus vaccine

World

AFP
July 1, 2020

WASHINGTON: The US biotech firm Inovio reported preliminary but encouraging results on Tuesday from tests of an experimental coronavirus vaccine. Administered to 40 volunteers, it triggered an immune system response in 94 percent of those who completed the so-called phase one clinical trial, meaning they received two injections, four weeks apart.